1 reports of this reaction
1.9% of all ARGENTUM METALLICUM reports
#12 most reported adverse reaction
BRONCHIECTASIS is the #12 most commonly reported adverse reaction for ARGENTUM METALLICUM, manufactured by Natural Immunogenics Corp.dba SOVEREIGN NATURALS. There are 1 FDA adverse event reports linking ARGENTUM METALLICUM to BRONCHIECTASIS. This represents approximately 1.9% of all 54 adverse event reports for this drug.
Patients taking ARGENTUM METALLICUM who experience bronchiectasis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BRONCHIECTASIS is a less commonly reported adverse event for ARGENTUM METALLICUM, but still significant enough to appear in the safety profile.
In addition to bronchiectasis, the following adverse reactions have been reported for ARGENTUM METALLICUM:
The following drugs have also been linked to bronchiectasis in FDA adverse event reports:
BRONCHIECTASIS has been reported as an adverse event in 1 FDA reports for ARGENTUM METALLICUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
BRONCHIECTASIS accounts for approximately 1.9% of all adverse event reports for ARGENTUM METALLICUM, making it a notable side effect.
If you experience bronchiectasis while taking ARGENTUM METALLICUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.